SIRT1 and endometrial cancer: In vivo studies have proposed several pathways of SIRT1 inhibition by EX-527, including limiting cell proliferation stimulated by SIRT1 in a mice model of endometrial cancer, and increasing the rate of clearance of mHtt by increasing the acetylation of mHtt exon 1 in a mice model for Huntington's disease.